Since January 2004, a pediatric liver transplant program has been implemented
at ISMETT in Palermo with the goal of meeting pediatric needs of central
and southern Italy.
Around 500,000 children are born every year in Italy; and since it has been
estimated that two children out of 10,000 newborns have liver diseases which
will require a liver transplant, this means that in Italy the need for a
pediatric transplant translates into approximately 100 cases per year.
Liver transplant is the therapy of choice for a number of liver diseases in the
pediatric age that develop into end-stage
liver failure.
Cholestatic
diseases and metabolic congenital defects are the two groups of diseases that on the whole require a transplant in more
than 90% of children.
Other liver diseases that do not bring about end-stage liver disease can also
lead to the need for a liver transplant. These are:
Non-progressive liver diseases with greater morbility than in liver transplants
Cystic fibrosis
Up
Children eligible for a liver transplant should undergo
an assessment as
soon as possible to outline effective need for transplant and identify
the clinical conditions that can be treated by a medical therapy.
At the end of the pre-transplant assessment, it is
important to define as accurately as possible the
severity rate of the disease in order to establish the urgency level
of the single patient
within the waiting list, as compared to the other candidates.
At the end of the assessment process, provided the
medical conditions allow for it, the patient is
sent home after having contacted the referring pediatrician, who is
requested to inform the
transplant center about any significant variation
in the child's clinical situation.
Up

Surgeries
currently performed for pediatric liver transplants are:
In whole-liver transplants,
the whole liver is procured from a cadaveric donor whose weight is similar to
the recipient's. Usually the weight ratio between donor and recipient is 1: 2.
Reduced-liver transplant. With this kind of surgery, the whole liver is procured from an adult cadaveric
donor and a procedure similar to liver resection is performed on
it on the backtable.
Though using adult livers for children solves the problem
of the lack of adequate-sized organs for pediatric
recipients, in practice this technique has shifted
the issue from pediatric to adult
waiting lists (much longer).
Living
donor liver transplant. In 1988, we find the first description of a surgery in which the II and the
III segment has been procured from a living donor
(mother) and transplanted into a child with biliary atresia.
Living donor liver transplants have been widely discussed with reference to the
ethics of having a healthy person undergo major
surgery, such as left hepatectomy, with all related risks. The legitimacy
of this
procedure has been recognized, and more than 1,200
surgeries of this kind have been performed worldwide, with a mortality
and morbility
for the donors of approximately 0.2% and 10% respectively.
To minimize the risks associated with the operation, potential donors
undergo
extremely accurate tests to assess their psychophysical
eligibility.
For pediatric recipients, living donor transplants in most
cases produce excellent results, due mainly to the
possibility of transplanting children before their
clinical conditions worsen.
Up

The main goals of long-term
follow-up of pediatric patients after liver transplant
are:
Monitor the graft's functions. Even months or years after the transplant, some changes in liver function levels
may occur, which need to be correctly interpreted
and treated.
Monitor side effects and drug interactions. The medications used after a liver transplant have a number of side effects
which should be adequately monitored and, if
possible, prevented. With children, one of the main goals of medium-
and long-term follow-up
is to foster their growth, often seriously
compromised by the liver disease. It has been proved that adequate
growth rarely occurs when
cortisone is chronically administered. Every-other-day
administration and steroid suspension are goals to be strenuously pursued.
Both cyclosporine
and tacrolimus are nephrotoxic drugs. It seems
almost certain that the most severe kidney damage occurs in the first
weeks following the
transplant, when the levels of these drugs are
at their highest.
Psycological Support. A number of research studies have proved that, even in the long term, serious
liver diseases in pediatric patients negatively
affect the development of the central nervous system and
of the cognitive
faculties. Also, given the period of psychological
stress for both patients and families, liver transplants
may leave
emotional scars. Pediatric transplant recipients
should be adequately assisted from a psychological standpoint
at least
for the first months or years after the transplant.
Psychological support may often be significant for the whole
family, which
is sometimes seriously affected.
Up

Thanks to modern immunosuppressants,
new surgical techniques which have virtually eliminated
mortality from pediatric waiting lists, and improved
knowledge of long-term issues
regarding transplanted patients, transplanted children
can grow and live an almost ordinary life.
However, liver transplants, like other the organ transplant procedures are not
finished products, and there is large room for
improvement, which will in large part be made possible
thanks to research. Recent advances in
surgical techniques, particularly the split liver, have virtually eliminated mortality from pediatric waiting lists, and after
five years the expected survival rate is nowadays approximately
85%. It is feasible for transplanted children to become adults and live
an
almost normal social life except for the tests they
will continually have to undergo to assess the correct functioning of
the transplant and
monitor the risks of chronic immunosuppression. At
the moment, accurate long-term follow-up is the most powerful tool to
safeguard the health
of transplanted children.
Up